Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A survey of experts to identify methods to detect problematic studies: Stage 1 of the INSPECT-SR Project.
Wilkinson J, Heal C, Antoniou GA, Flemyng E, Avenell A, Barbour V, Bordewijk EM, Brown NJL, Clarke M, Dumville J, Grohmann S, Gurrin LC, Hayden JA, Hunter KE, Lam E, Lasserson T, Li T, Lensen S, Liu J, Lundh A, Meyerowitz-Katz G, Mol BW, O'Connell NE, Parker L, Redman B, Seidler AL, Sheldrick K, Sydenham E, Dahly DL, van Wely M, Bero L, Kirkham JJ. Wilkinson J, et al. Among authors: lasserson t. medRxiv [Preprint]. 2024 Mar 25:2024.03.18.24304479. doi: 10.1101/2024.03.18.24304479. medRxiv. 2024. PMID: 38585914 Free PMC article. Preprint.
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions.
Wilkinson J, Heal C, Antoniou GA, Flemyng E, Alfirevic Z, Avenell A, Barbour V, Brown NJL, Carlisle J, Clarke M, Dicker P, Dumville J, Grey A, Grohmann S, Gurrin LC, Hayden JA, Heathers J, Hunter KE, Lasserson T, Lam E, Lensen S, Li T, Li W, Loder E, Lundh A, Meyerowitz-Katz G, Mol BW, O' Connell NE, Parker L, Redman BK, Seidler AL, Sheldrick KA, Sydenham E, Torgerson DJ, van Wely M, Wang R, Bero L, Kirkham JJ. Wilkinson J, et al. Among authors: lasserson t. medRxiv [Preprint]. 2023 Nov 13:2023.09.21.23295626. doi: 10.1101/2023.09.21.23295626. medRxiv. 2023. PMID: 37873409 Free PMC article. Updated. Preprint.
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions.
Wilkinson J, Heal C, Antoniou GA, Flemyng E, Alfirevic Z, Avenell A, Barbour G, Brown NJL, Carlisle J, Clarke M, Dicker P, Dumville JC, Grey A, Grohmann S, Gurrin L, Hayden JA, Heathers J, Hunter KE, Lasserson T, Lam E, Lensen S, Li T, Li W, Loder E, Lundh A, Meyerowitz-Katz G, Mol BW, O'Connell NE, Parker L, Redman BK, Seidler L, Sheldrick KA, Sydenham E, Torgerson D, van Wely M, Wang R, Bero L, Kirkham JJ. Wilkinson J, et al. Among authors: lasserson t. BMJ Open. 2024 Mar 11;14(3):e084164. doi: 10.1136/bmjopen-2024-084164. BMJ Open. 2024. PMID: 38471680 Free PMC article.
Policy makers must act on incomplete evidence in responding to COVID-19.
Soares-Weiser K, Lasserson T, Jorgensen KJ, Woloshin S, Bero L, Brown MD, Fischhoff B. Soares-Weiser K, et al. Among authors: lasserson t. Cochrane Database Syst Rev. 2020 Nov 20;11(11):ED000149. doi: 10.1002/14651858.ED000149. Cochrane Database Syst Rev. 2020. PMID: 33215686 Free PMC article. No abstract available.
RoB 2: a revised tool for assessing risk of bias in randomised trials.
Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT. Sterne JAC, et al. Among authors: lasserson t. BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898. BMJ. 2019. PMID: 31462531 Free article. No abstract available.
137 results